preEMBER
Eli Lilly and Company
Eli Lilly and Company
Necmettin Erbakan University
Peking University Cancer Hospital & Institute
Antalya City Hospital
Ruijin Hospital
Institut Bergonié
Institut Curie
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Xijing Hospital
Memorial Sloan Kettering Cancer Center
Hôpital du Valais
Ruijin Hospital
Peter MacCallum Cancer Centre, Australia
University of Cincinnati
Fudan University
AntiCancer Research Jamaica
Hebei Medical University Fourth Hospital
University of Rochester
Al-Quds University
BioLite, Inc.
National Cancer Institute (NCI)
Canadian Cancer Trials Group
National Cancer Institute (NCI)
Atlas University
University of Southern Queensland
Assiut University
Odense University Hospital
The First Affiliated Hospital with Nanjing Medical University
Regor Pharmaceuticals Inc.
Hoffmann-La Roche
Massachusetts General Hospital
Dana-Farber Cancer Institute
Institut fuer Frauengesundheit
Duke University
Providence Health & Services
Loyola University
Sichuan Baili Pharmaceutical Co., Ltd.
Alliance for Clinical Trials in Oncology
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Xiamen University
University of California, San Francisco
Fudan University
Peter MacCallum Cancer Centre, Australia
Rovi Pharmaceuticals Laboratories
Fudan University
Legacy Health System
Poitiers University Hospital
Capital Medical University
University of Miami
Karolinska Institutet